Table 1.
Main demographic and clinical data of the treated and control group
| Treated group | Control group | P value | |
|---|---|---|---|
|
Male: female |
14:10 |
16:8 |
0.55 |
|
Age (years) |
54.4 ± 12.3 |
55.4 ± 9.6 |
0.78 |
|
Follow-up (months) |
22.7 ± 23.4 |
36.2 ± 24.2 |
0.04 |
|
Number vascular risk factors* |
1.4 ± 1.1 |
1.6 ± 1.1 |
0.60 |
|
Crowded disc |
10 (42%) |
13 (54%) |
0.31 |
|
Mean VA (LogMAR) |
0.54 ± 0.67 |
0.54 ± 0.49 |
0.80 |
|
Visual field parameters |
|
|
|
|
Mean quadrant involvement |
2.4 ± 0.8 |
2.0 ± 0.6 |
0.007 |
| Mean MD | 9.7 ± 10.4 | 9.3 ± 10.5 | 0.9 |
VA = Visual acuity, MD = Mean deviation.
*Includes: Hypertention, diabetes mellitus, ischemic heart disease, dyslipidemia and smoking.